Related Experiment Video
Updated: May 7, 2026

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics
Published on: March 26, 2018
Mechanical Dialogues of Life and Death: How External Molecules Entry Triggers a Chromatin-Cytoskeleton Morphogenetic
Parama Dey1,2, Anup Singhania1,3,4, Ajaikumar B Kunnumakkara1
1Cancer Biology Laboratory, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati (IITG), Guwahati, Assam, India.
Abstract:
The next-generation anti-cancer therapeutics must disrupt intracellular mechanics, efficiently eradicating cancer cells, rather than simply intoxicating them. We evaluate the mechanism of action of PCMS, a PAMAM-based supramolecule that eradicates cancer cells by reorganizing their internal mechanics rather than their genes. Once internalized, PCMS self-assembles into a perinuclear ring that severs nucleus-cytoskeleton communication. We observed PCMS's dual-intelligent mechanisms of action: Cytoskeletal rescue, where actin-microtubule filaments move towards the PCMS ring, treating it as a surrogate plasma membrane, attempting to restore vesicular trafficking; Nuclear counter-expansion, where chromatin-lamina condensates undergo stepwise viscoelastic transitions that push the nuclear envelope outward to reestablish membrane contact. These contradictory forces amplify mechanical stress, driving super-critical strain and nuclear lysis without broad transcriptional modulations. By geometry alone, PCMS collapses the actin-microtubule-nucleus continuum and turns the cell's adaptive machinery into its own executioner. The discovery that life and death decisions can be reprogrammed through spatial conflict establishes a paradigm of mechanical deception, inaugurating a new class of cellular adaptive feedback-targeted mechanotherapeutics that overcome resistance by exploiting the cell's own morphogenetic logic.
Insights
Next-generation cancer therapy uses PCMS (PAMAM-based supramolecule) to mechanically disrupt cancer cells. This novel mechanotherapeutic reprograms cellular mechanics, leading to cancer cell death by exploiting internal adaptive feedback loops.
Area of Science:
- Biotechnology
- Nanomedicine
- Cellular Mechanics
Background:
- Next-generation anti-cancer therapeutics require novel mechanisms beyond simple toxicity.
- Disrupting intracellular mechanics offers a new strategy for cancer cell eradication.
- PAMAM-based supramolecules (PCMS) are emerging as potential agents for targeted cellular manipulation.
Purpose of the Study:
- To evaluate the mechanism of action of PCMS, a PAMAM-based supramolecule, in eradicating cancer cells.
- To investigate how PCMS reorganizes intracellular mechanics to induce cancer cell death.
- To establish PCMS as a novel class of mechanotherapeutics targeting cellular adaptive feedback.
Main Methods:
- Internalization and self-assembly of PCMS within cancer cells.
- Observation of PCMS-induced perinuclear ring formation and nucleus-cytoskeleton communication disruption.
- Analysis of cytoskeletal rescue and nuclear counter-expansion phenomena using advanced microscopy and biophysical techniques.
Main Results:
- PCMS self-assembles into a perinuclear ring, severing nucleus-cytoskeleton communication.
- Observed dual mechanisms: cytoskeletal rescue and nuclear counter-expansion, leading to amplified mechanical stress.
- PCMS induces nuclear lysis via geometric collapse of the actin-microtubule-nucleus continuum without significant transcriptional changes.
Conclusions:
- PCMS eradicates cancer cells by mechanically disrupting intracellular processes, not by genetic modification.
- The study establishes a paradigm of 'mechanical deception' for cancer therapy.
- PCMS represents a new class of mechanotherapeutics that exploit cellular morphogenetic logic to overcome resistance.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Cell Migration through Invadopodia
The Intrinsic Apoptotic Pathway
Cell-matrix's Response to Mechanical Forces
Anchoring junctions mechanically attach a cell to the...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

